Literature DB >> 28276995

Monoclonal antibodies and bacterial virulence.

Mirella Luciani1, Luigi Iannetti1.   

Abstract

Keywords:  Staphylococcus aureus; bacteria; immunotherapy; monoclonal antibodies; therapeutic antibodies

Mesh：

Substances：

Year:  2017        PMID： 28276995      PMCID： PMC5626250          DOI： 10.1080/21505594.2017.1292199

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  11 in total

Review 1.  Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.

Authors:  Jan Ter Meulen
Journal:  Infect Dis Clin North Am       Date:  2011-12       Impact factor: 5.982

Review 2.  Anti-bacterial monoclonal antibodies: back to the future?

Authors:  Martin B Oleksiewicz; Gábor Nagy; Eszter Nagy
Journal:  Arch Biochem Biophys       Date:  2012-06-13       Impact factor: 4.013

3.  Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.

Authors:  Bo Liu; Saeyoung Park; Christopher D Thompson; Xue Li; Jean C Lee
Journal:  Virulence       Date:  2016-12-09       Impact factor: 5.882

4.  Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.

Authors:  Jorge L Aguilar; Avanish K Varshney; Ximo Pechuan; Kaushik Dutta; Joshua D Nosanchuk; Bettina C Fries
Journal:  Virulence       Date:  2016-10-07       Impact factor: 5.882

5.  Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.

Authors:  Yilong Yang; Mengying Qian; Shaoqiong Yi; Shuling Liu; Bing Li; Rui Yu; Qiang Guo; Xiaopeng Zhang; Changming Yu; Jianmin Li; Junjie Xu; Wei Chen
Journal:  PLoS One       Date:  2016-02-29       Impact factor: 3.240

6.  Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.

Authors:  Valéria Szijártó; Luis M Guachalla; Katharina Hartl; Cecília Varga; Adriana Badarau; Irina Mirkina; Zehra C Visram; Lukas Stulik; Christine A Power; Eszter Nagy; Gábor Nagy
Journal:  Virulence       Date:  2017-01-19       Impact factor: 5.882

Review 7.  Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology.

Authors:  Jody D Berry; Ryan G Gaudet
Journal:  N Biotechnol       Date:  2011-04-05       Impact factor: 5.079

Review 8.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

9.  MAE4, an eLtaS monoclonal antibody, blocks Staphylococcus aureus virulence.

Authors:  Yu Liu; Jiannan Feng; Qiang Lu; Xin Zhang; Yaping Gao; Jun Yan; Chunhua Mu; Yan Hei; Ming Lv; Gencheng Han; Guojiang Chen; Peng Jin; Weiguo Hu; Beifen Shen; Guang Yang
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

10.  Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance.

Authors:  Erin K Sully; Natalia Malachowa; Bradley O Elmore; Susan M Alexander; Jon K Femling; Brian M Gray; Frank R DeLeo; Michael Otto; Ambrose L Cheung; Bruce S Edwards; Larry A Sklar; Alexander R Horswill; Pamela R Hall; Hattie D Gresham
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823
View more
  2 in total

Review 1.  Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.

Authors:  Hui Wang; Daijie Chen; Huili Lu
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-01       Impact factor: 4.813

Review 2.  Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases.

Authors:  Pietro Speziale; Simonetta Rindi; Giampiero Pietrocola
Journal:  Microorganisms       Date:  2018-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.